Takeo Isozaki

1.2k total citations
55 papers, 930 citations indexed

About

Takeo Isozaki is a scholar working on Rheumatology, Oncology and Immunology. According to data from OpenAlex, Takeo Isozaki has authored 55 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Rheumatology, 19 papers in Oncology and 12 papers in Immunology. Recurrent topics in Takeo Isozaki's work include Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (12 papers) and Cell Adhesion Molecules Research (10 papers). Takeo Isozaki is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (12 papers) and Cell Adhesion Molecules Research (10 papers). Takeo Isozaki collaborates with scholars based in Japan, United States and Netherlands. Takeo Isozaki's co-authors include Tsuyoshi Kasama, Nobuyuki Yajima, Jeffrey H. Ruth, Mizuho Matsunawa, Alisa E. Koch, Tsuyoshi Odai, Kuninobu Wakabayashi, Yusuke Miwa, M. Asif Amin and Hirotsugu Ide and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Takeo Isozaki

53 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takeo Isozaki Japan	20	363	324	312	244	129	55	930
Consuelo Anzilotti United Kingdom	17	315 0.9×	389 1.2×	258 0.8×	455 1.9×	96 0.7×	24	1.1k
Elisa Corsiero United Kingdom	12	291 0.8×	468 1.4×	115 0.4×	340 1.4×	53 0.4×	25	995
María‐Eugenia Miranda‐Carús Spain	17	465 1.3×	529 1.6×	126 0.4×	188 0.8×	51 0.4×	30	1.0k
Mitsuko Sasai Japan	7	423 1.2×	408 1.3×	593 1.9×	241 1.0×	93 0.7×	9	1.2k
Hélder Trindade Portugal	17	156 0.4×	421 1.3×	161 0.5×	353 1.4×	70 0.5×	42	985
Thomas Karonitsch Austria	19	464 1.3×	355 1.1×	151 0.5×	236 1.0×	47 0.4×	41	984
Taiichiro Miyashita Japan	18	310 0.9×	299 0.9×	144 0.5×	277 1.1×	108 0.8×	50	845
Kei Sakata Japan	15	373 1.0×	432 1.3×	128 0.4×	216 0.9×	88 0.7×	21	905
Chul-Soo Cho South Korea	14	193 0.5×	292 0.9×	142 0.5×	278 1.1×	47 0.4×	15	816
Eva Emmell United States	12	136 0.4×	371 1.1×	237 0.8×	297 1.2×	66 0.5×	18	1.0k

Countries citing papers authored by Takeo Isozaki

Since Specialization

Citations

This map shows the geographic impact of Takeo Isozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Isozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Isozaki more than expected).

Fields of papers citing papers by Takeo Isozaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Isozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Isozaki. The network helps show where Takeo Isozaki may publish in the future.

Co-authorship network of co-authors of Takeo Isozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Isozaki. A scholar is included among the top collaborators of Takeo Isozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Isozaki. Takeo Isozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Korchynskyi, Olexandr, Ken Yoshida, Paul P. Tak, et al.. (2023). Mammalian Glycosylation Patterns Protect Citrullinated Chemokine MCP-1/CCL2 from Partial Degradation. International Journal of Molecular Sciences. 24(3). 1862–1862. 2 indexed citations

Isozaki, Takeo, Kuninobu Wakabayashi, Noriyuki Konishi, et al.. (2021). POS0429 INTERLEUKIN-4 ACTIVATES EOSINOPHILS AND CCR3-POSITIVE T HELPER CELLS MIGRATION TO FASCIA AND PROMOTES FIBROSIS IN EOSINOPHILIC FASCIITIS. Annals of the Rheumatic Diseases. 80. 443–443. 1 indexed citations

Isozaki, Takeo, et al.. (2018). ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease. Clinical Rheumatology. 37(4). 1017–1024. 10 indexed citations

Ishii, Sho, et al.. (2018). ADAM-17 is expressed on rheumatoid arthritis fibroblast-like synoviocytes and regulates proinflammatory mediator expression and monocyte adhesion. Arthritis Research & Therapy. 20(1). 159–159. 20 indexed citations

Isozaki, Takeo, et al.. (2017). SAT0322 ADAM-17 is expressed in the inflammatory myopathy, and is involved with interstitial lung disease (ILD). Annals of the Rheumatic Diseases. 76. 894–894. 1 indexed citations

Miwa, Yusuke, Nobuyuki Yajima, Takeo Isozaki, et al.. (2017). SAT0085 A study on characteristics of rheumatoid arthritis patients achieving depression remission with 6 months of biologic agent treatment. Annals of the Rheumatic Diseases. 76. 800–801. 1 indexed citations

Odai, Tsuyoshi, Takeo Isozaki, Tsuyoshi Kasama, Etsuro Ogata, & Eriko Kinugasa. (2015). Therapeutic Efficacy of Leukocytapheresis in a Pregnant Woman with Refractory Adult-onset Still's Disease. Internal Medicine. 54(17). 2261–2266. 7 indexed citations

Isozaki, Takeo, Jeffrey H. Ruth, M. Asif Amin, et al.. (2014). Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation. Arthritis Research & Therapy. 16(1). R28–R28. 33 indexed citations

Isozaki, Takeo, M. Asif Amin, Ali S. Arbab, et al.. (2014). Inhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritis. Arthritis Research & Therapy. 16(2). R68–R68. 10 indexed citations

10.

Kasama, Tsuyoshi, Masanori Nakamura, Katsunori Inagaki, et al.. (2014). Reduction of Serum ADAM17 Level Accompanied with Decreased Cytokines after Abatacept Therapy in Patients with Rheumatoid Arthritis. International Journal of Biomedical Science. 10(4). 229–235. 24 indexed citations

11.

Isozaki, Takeo, Ali S. Arbab, Christian S. Haas, et al.. (2013). Evidence That CXCL16 Is a Potent Mediator of Angiogenesis and Is Involved in Endothelial Progenitor Cell Chemotaxis: Studies in Mice With K/BxN Serum–Induced Arthritis. Arthritis & Rheumatism. 65(7). 1736–1746. 65 indexed citations

12.

Isozaki, Takeo, Bradley J. Rabquer, Jeffrey H. Ruth, G. Kenneth Haines, & Alisa E. Koch. (2012). ADAM‐10 is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesis. Arthritis & Rheumatism. 65(1). 98–108. 41 indexed citations

13.

Isozaki, Takeo, et al.. (2010). Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis. SHILAP Revista de lepidopterología. 1 indexed citations

14.

Isozaki, Takeo, Ryo Takahashi, Kuninobu Wakabayashi, et al.. (2010). Synergistic induction of CX3CL1 by interleukin-1β and interferon-γ in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways. Translational research. 157(2). 64–70. 28 indexed citations

15.

Muramatsu, M, Ryo Takahashi, Kuninobu Wakabayashi, et al.. (2010). Dermatomyositis complicated with hemorrhagic shock of the iliopsoas muscle on both sides and the thigh muscle. Modern Rheumatology. 20(4). 420–422. 6 indexed citations

16.

Odai, Tsuyoshi, Mizuho Matsunawa, Ryo Takahashi, et al.. (2009). Correlation of CX3CL1 and CX3CR1 Levels with Response to Infliximab Therapy in Patients with Rheumatoid Arthritis. The Journal of Rheumatology. 36(6). 1158–1165. 36 indexed citations

17.

Kasama, Tsuyoshi, et al.. (2009). Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy. Translational research. 155(1). 20–26. 27 indexed citations

18.

Matsunawa, Mizuho, Takeo Isozaki, Tsuyoshi Odai, et al.. (2006). Increased serum levels of soluble fractalkine (CX₃CL1) correlate with disease activity in rheumatoid vasculitis. Arthritis & Rheumatism. 54(11). 3408–3416. 59 indexed citations

19.

Yoda, Yoshiyuki, Ryosuke Hanaoka, Hirotsugu Ide, et al.. (2006). Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia. Modern Rheumatology. 16(3). 137–142. 34 indexed citations

20.

Yajima, Nobuyuki, Tsuyoshi Kasama, Takeo Isozaki, et al.. (2005). Elevated levels of soluble fractalkine in active systemic lupus erythematosus: Potential involvement in neuropsychiatric manifestations. Arthritis & Rheumatism. 52(6). 1670–1675. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact